Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)

Date : 09/12/2018 @ 1:11PM
Source : Edgar (US Regulatory)
Stock : Cannabics Pharmaceuticals Inc. (QB) (CNBX)
Quote : 0.355  -0.023 (-6.08%) @ 9:00PM
Cannabics Pharmaceuticals Inc. share price Chart

Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)

Prospectus Supplement No. 4
(To Prospectus dated April 21, 2017)

Filed pursuant to Rule 424(b)(2)

Registration No. 333-216845

 

Cannabics Pharmaceuticals, Inc.

277,777 Shares of Common Stock

 

 

 

Pursuant to this prospectus supplement No. 4, the accompanying prospectus supplement filed May 31 st , 2018, and the accompanying prospectus, we are offering 277,777 shares of common stock to YAII PN Ltd. at a price of $0.90 per share, pursuant to our previously announced Standby Equity Distribution Agreement, or SEDA, dated April 30 th , 2018, with YAII PN, Ltd. Additionally we are registering these 277,777 shares representing $250,000.00 in proceeds we will receive from the sale of these shares. The purchase price for the shares issued under this Prospectus Supplement No. 4 is determined in accordance with the SEDA and represents 98% of the lowest daily VWAP during the five consecutive trading days after the date of the advance notice. “VWAP” means, as of any date, the daily dollar volume-weighted average price for such security as reported by Bloomberg, L.P.

 

These shares are being issued as part of the commitment by YAII PN Ltd. to purchase, from time to time, at our option, up to $10,000,000 of shares of our common stock pursuant to the SEDA.

 

We expect to issue the 277,777 shares to YAII PN, LTD. on or about September 12 th , 2018.

 

In addition to our issuance of common shares to YAII PN, LTD. pursuant to the SEDA, this prospectus supplement No. 4, the accompanying prospectus supplement and the accompanying prospectus also cover the resale of those shares by YAII PN, LTD. to the public. YAII PN, LTD. may be deemed to be an “underwriter” within the meaning of the Securities Act of 1933, as amended. For additional information on the methods of sale that may be used by YAII PN, LTD., see the section entitled “Plan of Distribution” of Prospectus Supplement dated May 31 st , 2018.

 

Our common stock is listed on the OTC Bulletin Board Market under the symbol “CNBX”. The last reported sale price of our common stock on OTC Bulletin Board Market on September 11 th , 2018, was $0.88 per share.

 

As of April 30 th , 2018, the date that we entered into the SEDA, the aggregate market value of our outstanding common stock held by non-affiliates was $33,101,404 based on a per share price of $1.06, based on 31,227,740 shares of outstanding common stock. During the twelve calendar months prior to and including the date hereof, we have not offered any securities pursuant to General Instruction I.B.6. of Form S-3. This is the second drawdown as of the date of this prospectus supplement.

 

Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page S-6 of Prospectus Supplement No. 1.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

September 12 th , 2018

   

 

 

     

 

 

THE OFFERING

 

Shares of Common Stock offered   277,777 shares of common stock of Cannabics Pharmaceuticals Inc.
     
Purchaser   YAII PN Ltd., pursuant to the Standby Equity Distribution Agreement dated April 30 th , 2018.
     
Purchase price   $0.90 per share, for an aggregate of $250,000. The price per share is determined in accordance with the SEDA, and represents 98% of the lowest daily VWAP during the five consecutive trading days after the date of the advance notice. “VWAP” means, as of any date, the daily dollar volume-weighted average price for such security as reported by Bloomberg, L.P. The “advance notice” for this portion was delivered August 27 th , 2018.
     
Settlement date   On or about September 12 th , 2018.
     
Use of proceeds   We intend to use the net proceeds from this offering for general corporate purposes, including the continuation of our research, clinical trials, collaboration arrangements and general working capital needs. See “Use of Proceeds” in the accompanying prospectus supplement.
     
Symbol for our common stock on the Nasdaq Capital Market   “CNBX”
     
Resale   This prospectus supplement, the accompanying prospectus supplement and the accompanying prospectus also cover the resale of shares by YAII PN, LTD. to the public. See “Plan of Distribution” in the accompanying prospectus supplement.

 

 

 

 

 

 

 

 

 

 

 

     

 

Cannabics Pharmaceuticals Inc. (USOTC:CNBX)
Historical Stock Chart

1 Year : From Dec 2017 to Dec 2018

Click Here for more Cannabics Pharmaceuticals Inc. Charts.

Cannabics Pharmaceuticals Inc. (USOTC:CNBX)
Intraday Stock Chart

Today : Tuesday 18 December 2018

Click Here for more Cannabics Pharmaceuticals Inc. Charts.

Latest CNBX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20181218 10:49:56